Introduction: Anemia is a common manifestation of chronic liver diseases. It is a predictor of severe disease, a high risk of complications, and poor outcomes in various liver diseases. However, it remains unclear whether anemia serves as a similar indicator in patients with Wilson disease (WD). Therefore, this study aimed to investigate the relationship between anemia and severity, hepatic complications, and the progression of WD. Methods: Medical data were collected retrospectively from January 1, 2016, to December 31, 2020. Univariate and multivariate analyses were carried out to investigate the relationship between anemia and liver-associated disease severity, hepatic complications, and the progression of WD. Results: A total of 288 WD patients (48 with and 240 without anemia) were enrolled in the study. Multivariate linear regression revealed that WD patients with anemia had significantly higher levels of bilirubin, alanine transaminase, prothrombin time, international normalized ratio, type Ⅳ collagen, and hyaluronic acid and significantly lower levels of albumin, total cholesterol, and high-density lipoprotein-cholesterol (all p < 0.05). Multivariate logistic regression showed that anemia was a risk factor for gastric varices and ascites (all p < 0.05). Fully adjusted Cox regression revealed that anemia was an independent risk factor for advanced Child-Pugh classification (p = 0.034). Conclusions: Anemia was common in WD patients and was associated with greater disease severity, a higher risk of hepatic complications, and a faster progression.

1.
Członkowska
A
,
Litwin
T
,
Dusek
P
,
Ferenci
P
,
Lutsenko
S
,
Medici
V
.
Wilson disease
.
Nat Rev Dis Primers
.
2018
;
4
(
1
):
21
.
2.
Coffey
AJ
,
Durkie
M
,
Hague
S
,
McLay
K
,
Emmerson
J
,
Lo
C
.
A genetic study of Wilson’s disease in the United Kingdom
.
Brain
.
2013
136
Pt 5
1476
87
.
3.
Gao
J
,
Brackley
S
,
Mann
JP
.
The global prevalence of Wilson disease from next-generation sequencing data
.
Genet
.
Med2019 May
21
5
1155
63
.
4.
Fernando
M
,
van Mourik
I
,
Wassmer
E
,
Kelly
D
.
Wilson disease in children and adolescents
.
Arch Dis Child
.
2020
;
105
(
5
):
499
505
.
5.
Roberts
EA
,
Socha
P
.
Wilson disease in children
.
Handb Clin Neurol
.
2017
;
142
:
141
56
.
6.
Ferenci
P
,
Stremmel
W
,
Członkowska
A
,
Szalay
F
,
Viveiros
A
,
Stattermayer
AF
.
Age and sex but not ATP7B genotype effectively influence the clinical phenotype of Wilson disease
.
Hepatology
.
2019
;
69
(
4
):
1464
76
.
7.
Mulligan
C
,
Bronstein
JM
.
Wilson disease: an overview and approach to management
.
Neurol Clin
.
2020
;
38
(
2
):
417
32
.
8.
Caraceni
P
,
Tufoni
M
,
Zaccherini
G
,
Riggio
O
,
Angeli
P
,
Alessandria
C
.
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites
.
J Hepatol
.
2021
;
74
(
2
):
340
9
.
9.
Trieb
M
,
Rainer
F
,
Stadlbauer
V
,
Douschan
P
,
Horvath
A
,
Binder
L
.
HDL-related biomarkers are robust predictors of survival in patients with chronic liver failure
.
J Hepatol
.
2020
;
73
(
1
):
113
20
.
10.
Piano
S
,
Tonon
M
,
Vettore
E
,
Stanco
M
,
Pilutti
C
,
Romano
A
.
Incidence, predictors and outcomes of acute-on-chronic liver failure in outpatients with cirrhosis
.
J Hepatol
.
2017
;
67
(
6
):
1177
84
.
11.
Zhong
HJ
,
Zhuang
YP
,
Zhang
YT
,
Xu
SP
,
Hong
MF
,
He
XX
.
Distinguishing between the complications of Wilson disease-related cirrhosis and HBV-related cirrhosis
.
Curr Med Res Opin
.
2022
;
38
(
1
):
75
81
.
12.
Zhong
HJ
,
Sun
HH
,
Xue
LF
,
McGowan
EM
,
Chen
Y
.
Differential hepatic features presenting in Wilson disease-associated cirrhosis and hepatitis B-associated cirrhosis
.
World J Gastroenterol
.
2019
;
25
(
3
):
378
87
.
13.
Gkamprela
E
,
Deutsch
M
,
Pectasides
D
.
Iron deficiency anemia in chronic liver disease: etiopathogenesis, diagnosis and treatment
.
Ann Gastroenterol
.
2017
;
30
(
4
):
405
13
.
14.
Scheiner
B
,
Semmler
G
,
Maurer
F
,
Schwabl
P
,
Bucsics
TA
,
Paternostro
R
.
Prevalence of and risk factors for anaemia in patients with advanced chronic liver disease
.
Liver Int
.
2020
;
40
(
1
):
194
204
.
15.
Novo-Veleiro
I
,
Herrera-Flores
J
,
Roson-Hernandez
B
,
Medina-Garcia
JA
,
Muga
R
,
Fernandez-Sola
J
.
Alcoholic liver disease among patients with Wernicke encephalopathy: a multicenter observational study
.
Drug Alcohol Depend
.
2022
;
230
:
109186
.
16.
Xu
Z
,
Berry
BR
.
Oxidative hemolysis due to Wilson disease
.
Blood
.
2019
;
134
(
7
):
657
.
17.
Forman
SJ
,
Kumar
KS
,
Redeker
AG
,
Hochstein
P
.
Hemolytic anemia in Wilson disease: clinical findings and biochemical mechanisms
.
Am J Hematol
.
1980
;
9
(
3
):
269
75
.
18.
Cai
J
,
Wu
M
,
Ren
J
,
Du
Y
,
Long
Z
,
Li
G
.
Evaluation of the efficiency of the reticulocyte hemoglobin content on diagnosis for iron deficiency anemia in Chinese adults
.
Nutrients
.
2017
;
9
(
5
):
450
.
19.
Driever
EG
,
Stravitz
RT
,
Zhang
J
,
Adelmeijer
J
,
Durkalski
V
,
Lee
WM
.
VWF/ADAMTS13 imbalance, but not global coagulation or fibrinolysis, is associated with outcome and bleeding in acute liver failure
.
Hepatology
.
2021
;
73
(
5
):
1882
91
.
20.
Piano
S
,
Rosi
S
,
Maresio
G
,
Fasolato
S
,
Cavallin
M
,
Romano
A
.
Evaluation of the acute kidney injury network criteria in hospitalized patients with cirrhosis and ascites
.
J Hepatol
.
2013
;
59
(
3
):
482
9
.
21.
Riordan
SM
,
Williams
R
.
Treatment of hepatic encephalopathy
.
N Engl J Med
.
1997
;
337
(
7
):
473
9
.
22.
Jachs
M
,
Hartl
L
,
Simbrunner
B
,
Bauer
D
,
Paternostro
R
,
Scheiner
B
.
Decreasing von Willebrand factor levels upon nonselective beta blocker therapy indicate a decreased risk of further decompensation, acute-on-chronic liver failure, and death
.
Clin Gastroenterol Hepatol
.
2022
;
20
(
6
):
1362
73.e6
.
23.
Sterling
RK
,
Lissen
E
,
Clumeck
N
,
Sola
R
,
Correa
MC
,
Montaner
J
.
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection
.
Hepatology
.
2006
;
43
(
6
):
1317
25
.
24.
Lin
ZH
,
Xin
YN
,
Dong
QJ
,
Wang
Q
,
Jiang
XJ
,
Zhan
SH
.
Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis
.
Hepatology
.
2011
;
53
(
3
):
726
36
.
25.
Pugh
RN
,
Murray-Lyon
IM
,
Dawson
JL
,
Pietroni
MC
,
Williams
R
.
Transection of the oesophagus for bleeding oesophageal varices
.
Br J Surg
.
1973
;
60
(
8
):
646
9
.
26.
Zhong
HJ
,
Xiao
P
,
Lin
D
,
Zhou
HM
,
He
XX
.
Cirrhosis in Wilson disease is characterized by impaired hepatic synthesis, leukopenia and thrombocytopenia
.
Int J Med Sci
.
2020
;
17
(
10
):
1345
50
.
27.
Qamar
AA
,
Grace
ND
,
Groszmann
RJ
,
Garcia-Tsao
G
,
Bosch
J
,
Burroughs
AK
.
Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis
.
Clin Gastroenterol Hepatol
.
2009
;
7
(
6
):
689
95
.
28.
Sahin
A
,
Artas
H
,
Tunc
N
,
Yalniz
M
,
Bahcecioglu
IH
.
Hematological indices in portal hypertension: cirrhosis versus noncirrhotic portal hypertension
.
J Clin Med
.
2018
;
7
(
8
):
196
.
29.
Poon
TC
,
Hui
AY
,
Chan
HL
,
Ang
IL
,
Chow
SM
,
Wong
N
.
Prediction of liver fibrosis and cirrhosis in chronic hepatitis B infection by serum proteomic fingerprinting: a pilot study
.
Clin Chem
.
2005
;
51
(
2
):
328
35
.
30.
Dzieżyc-Jaworska
K
,
Litwin
T
,
Członkowska
A
.
Clinical manifestations of Wilson disease in organs other than the liver and brain
.
Ann Transl Med
.
2019
7
Suppl 2
S62
.
31.
Varghese
J
,
Varghese James
J
,
Karthikeyan
M
,
Rasalkar
K
,
Raghavan
R
,
Sukumaran
A
.
Iron homeostasis is dysregulated, but the iron-hepcidin axis is functional, in chronic liver disease
.
J Trace Elem Med Biol
.
2020
;
58
:
126442
.
32.
Jończy
A
,
Lipiński
P
,
Ogorek
M
,
Starzyński
RR
,
Krzysztofik
D
,
Bednarz
A
.
Functional iron deficiency in toxic milk mutant mice (tx-J) despite high hepatic ferroportin: a critical role of decreased GPI-ceruloplasmin expression in liver macrophages
.
Metallomics
.
2019
;
11
(
6
):
1079
92
.
33.
Paternostro
R
,
Kapzan
L
,
Mandorfer
M
,
Schwarzer
R
,
Benedikt
S
,
Viveiros
A
.
Anemia and iron deficiency in compensated and decompensated cirrhosis: prevalence and impact on clinical outcomes
.
J Gastroenterol Hepatol
.
2020
;
35
(
9
):
1619
27
.
34.
Wooton-Kee
CR
,
Jain
AK
,
Wagner
M
,
Grusak
MA
,
Finegold
MJ
,
Lutsenko
S
.
Elevated copper impairs hepatic nuclear receptor function in Wilson’s disease
.
J Clin Invest
.
2015
;
125
(
9
):
3449
60
.
35.
Li
T
,
Chiang
JY
.
Bile acid signaling in metabolic disease and drug therapy
.
Pharmacol Rev
.
2014
;
66
(
4
):
948
83
.
36.
Dzieżyc
K
,
Litwin
T
,
Sobańska
A
,
Członkowska
A
.
Symptomatic copper deficiency in three Wilson’s disease patients treated with zinc sulphate
.
Neurol Neurochir Pol
.
2014
;
48
(
3
):
214
8
.
37.
Harada
M
,
Miyagawa
K
,
Honma
Y
,
Hiura
M
,
Shibata
M
,
Matsuhashi
T
.
Excess copper chelating therapy for Wilson disease induces anemia and liver dysfunction
.
Intern Med
.
2011
;
50
(
14
):
1461
4
.
38.
Nie
K
,
Ran
R
,
Tan
W
,
Yi
B
,
Luo
X
,
Yu
Y
.
Risk factors of intra-abdominal bacterial infection after liver transplantation in patients with hepatocellular carcinoma
.
Chin J Cancer Res
.
2014
;
26
(
3
):
309
14
.
39.
Jiang
AA
,
Greenwald
HS
,
Sheikh
L
,
Wooten
DA
,
Malhotra
A
,
Schooley
RT
.
Predictors of acute liver failure in patients with acute hepatitis A: an analysis of the 2016-2018 San Diego county hepatitis A outbreak
.
Open Forum Infect Dis
.
2019
6
11
ofz467
.
40.
Suzuki
A
,
Lymp
J
,
Donlinger
J
,
Mendes
F
,
Angulo
P
,
Lindor
K
.
Clinical predictors for hepatocellular carcinoma in patients with primary biliary cirrhosis
.
Clin Gastroenterol Hepatol
.
2007
;
5
(
2
):
259
64
.
41.
Virk
ZM
,
Patel
AA
,
Leaf
RK
,
Al-Samkari
H
.
Predictors of mortality and outcomes of liver transplant in spur cell hemolytic anemia
.
Am J Hematol
.
2021
;
96
(
12
):
1611
20
.
42.
Chen
JF
,
Weng
WZ
,
Huang
M
,
Peng
XH
,
He
JR
,
Zhang
J
.
Derivation and validation of a nomogram for predicting 90-day survival in patients with HBV-related acute-on-chronic liver failure
.
Front Med
.
2021
;
8
:
692669
.
43.
Xu
J
,
Zhou
X
,
Zheng
C
.
The geriatric nutritional risk index independently predicts adverse outcomes in patients with pyogenic liver abscess
.
BMC Geriatr
.
2019
;
19
(
1
):
14
.
44.
Hu
XP
,
Gao
J
.
International normalized ratio and Model for End-stage Liver Disease score predict short-term outcome in cirrhotic patients after the resolution of hepatic encephalopathy
.
World J Gastroenterol
.
2019
;
25
(
26
):
3426
37
.
45.
Cochen De Cock
V
,
Woimant
F
,
Poujois
A
.
Sleep disorders in Wilson’s disease
.
Curr Neurol Neurosci Rep
.
2019
;
19
(
11
):
84
.
46.
Zhuang
YP
,
Zhong
HJ
.
Impact of COVID-19 on the clinical status of patients with Wilson disease
.
World J Gastroenterol
.
2021
;
27
(
26
):
4248
51
.
You do not currently have access to this content.